-transparent.png){kind=logo}
Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis. 2004
G Cavaletti, and
E Cavalletti, and
L Crippa, and
E Di Luccio, and
N Oggioni, and
B Mazzanti, and
T Biagioli, and
F Sala, and
V Sala, and
M Frigo, and
S Rota, and
E Tagliabue, and
L Stanzani, and
S Galbiati, and
R Rigolio, and
C Zoia, and
G Tredici, and
P Perseghin, and
M Dassi, and
P Riccio, and
F Lolli
Department of Neuroscience and Biomedical Technologies, University of Milan Bicocca, and Department of Neurology, S. Gerardo Hospital, Monza, Italy. guido.cavaletti@unimib.it
Pixantrone is less cardiotoxic and is similarly effective to mitoxantrone (MTX) as an antineoplastic drug. In our study, pixantrone reduced the severity of acute and decreased the relapse rate of chronic relapsing experimental allergic encephalomyelitis (EAE) in rats. A marked and long-lasting decrease in CD3+, CD4+, CD8+ and CD45RA+ blood cells and reduced anti-MBP titers were observed with both pixantrone and MTX. In vitro mitogen- and antigen-induced T-cell proliferation tests of human and rodents cells evidenced that pixantrone was effective at concentrations which can be effectively obtained after i.v. administration in humans. Cardiotoxicity was present only in MTX-treated rats. The effectiveness and the favorable safety profile makes pixantrone a most promising immunosuppressant agent for clinical use in multiple sclerosis (MS).
Related Publications
G Cavaletti, and
E Cavalletti, and
L Crippa, and
E Di Luccio, and
N Oggioni, and
B Mazzanti, and
T Biagioli, and
F Sala, and
V Sala, and
M Frigo, and
S Rota, and
E Tagliabue, and
L Stanzani, and
S Galbiati, and
R Rigolio, and
C Zoia, and
G Tredici, and
P Perseghin, and
M Dassi, and
P Riccio, and
F Lolli
February 2008,
Journal of immunology (Baltimore, Md. : 1950),
G Cavaletti, and
E Cavalletti, and
L Crippa, and
E Di Luccio, and
N Oggioni, and
B Mazzanti, and
T Biagioli, and
F Sala, and
V Sala, and
M Frigo, and
S Rota, and
E Tagliabue, and
L Stanzani, and
S Galbiati, and
R Rigolio, and
C Zoia, and
G Tredici, and
P Perseghin, and
M Dassi, and
P Riccio, and
F Lolli
July 2007,
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
G Cavaletti, and
E Cavalletti, and
L Crippa, and
E Di Luccio, and
N Oggioni, and
B Mazzanti, and
T Biagioli, and
F Sala, and
V Sala, and
M Frigo, and
S Rota, and
E Tagliabue, and
L Stanzani, and
S Galbiati, and
R Rigolio, and
C Zoia, and
G Tredici, and
P Perseghin, and
M Dassi, and
P Riccio, and
F Lolli
March 1988,
Journal of neuroimmunology,
G Cavaletti, and
E Cavalletti, and
L Crippa, and
E Di Luccio, and
N Oggioni, and
B Mazzanti, and
T Biagioli, and
F Sala, and
V Sala, and
M Frigo, and
S Rota, and
E Tagliabue, and
L Stanzani, and
S Galbiati, and
R Rigolio, and
C Zoia, and
G Tredici, and
P Perseghin, and
M Dassi, and
P Riccio, and
F Lolli
January 1988,
Annals of the New York Academy of Sciences,
G Cavaletti, and
E Cavalletti, and
L Crippa, and
E Di Luccio, and
N Oggioni, and
B Mazzanti, and
T Biagioli, and
F Sala, and
V Sala, and
M Frigo, and
S Rota, and
E Tagliabue, and
L Stanzani, and
S Galbiati, and
R Rigolio, and
C Zoia, and
G Tredici, and
P Perseghin, and
M Dassi, and
P Riccio, and
F Lolli
January 2009,
Journal of immunology (Baltimore, Md. : 1950),
G Cavaletti, and
E Cavalletti, and
L Crippa, and
E Di Luccio, and
N Oggioni, and
B Mazzanti, and
T Biagioli, and
F Sala, and
V Sala, and
M Frigo, and
S Rota, and
E Tagliabue, and
L Stanzani, and
S Galbiati, and
R Rigolio, and
C Zoia, and
G Tredici, and
P Perseghin, and
M Dassi, and
P Riccio, and
F Lolli
August 2004,
Journal of the neurological sciences,
G Cavaletti, and
E Cavalletti, and
L Crippa, and
E Di Luccio, and
N Oggioni, and
B Mazzanti, and
T Biagioli, and
F Sala, and
V Sala, and
M Frigo, and
S Rota, and
E Tagliabue, and
L Stanzani, and
S Galbiati, and
R Rigolio, and
C Zoia, and
G Tredici, and
P Perseghin, and
M Dassi, and
P Riccio, and
F Lolli
October 2017,
Journal of neuroinflammation,
G Cavaletti, and
E Cavalletti, and
L Crippa, and
E Di Luccio, and
N Oggioni, and
B Mazzanti, and
T Biagioli, and
F Sala, and
V Sala, and
M Frigo, and
S Rota, and
E Tagliabue, and
L Stanzani, and
S Galbiati, and
R Rigolio, and
C Zoia, and
G Tredici, and
P Perseghin, and
M Dassi, and
P Riccio, and
F Lolli
October 2020,
Journal of neuroinflammation,
G Cavaletti, and
E Cavalletti, and
L Crippa, and
E Di Luccio, and
N Oggioni, and
B Mazzanti, and
T Biagioli, and
F Sala, and
V Sala, and
M Frigo, and
S Rota, and
E Tagliabue, and
L Stanzani, and
S Galbiati, and
R Rigolio, and
C Zoia, and
G Tredici, and
P Perseghin, and
M Dassi, and
P Riccio, and
F Lolli
January 1988,
Methods in enzymology,
G Cavaletti, and
E Cavalletti, and
L Crippa, and
E Di Luccio, and
N Oggioni, and
B Mazzanti, and
T Biagioli, and
F Sala, and
V Sala, and
M Frigo, and
S Rota, and
E Tagliabue, and
L Stanzani, and
S Galbiati, and
R Rigolio, and
C Zoia, and
G Tredici, and
P Perseghin, and
M Dassi, and
P Riccio, and
F Lolli
March 1950,
Comptes rendus des seances de la Societe de biologie et de ses filiales,
